Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD83 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → CD83 |
| (<<) CHST11 → CD83 |
| (<<) CYP4F2 → CD83 |
| (<<) EBP → CD83 |
| (<<) GPNMB → CD83 |
| (<<) GPX1 → CD83 |
| (<<) HS3ST2 → CD83 |
| (<<) LPXN → CD83 |
| (<<) MMP9 → CD83 |
| (<<) ORM1 → CD83 |
| (<<) PLAU → CD83 |
| (<<) PLK3 → CD83 |
| (<<) RAC2 → CD83 |
| (<<) SYK → CD83 |
| (<<) TIMP2 → CD83 |
| (<<) VEGFC → CD83 |
| (<<) VIM → CD83 |
| Downstream (Children) |
|---|
| CD83 → ALOX15B (>>) |
| CD83 → ATP2A2 (>>) |
| CD83 → DUSP9 (>>) |
| CD83 → GLI3 (>>) |
| CD83 → HKDC1 (>>) |
| CD83 → MVK (>>) |
| CD83 → PDIA4 (>>) |
| CD83 → PLD3 (>>) |
| CD83 → TUBA8 (>>) |
| CD83 → UAP1 (>>) |
